Exploring the final frontier: Disease proposed as major barrier to Mars and beyondOctober 30, 2009New research published in the Journal of Leukocyte Biology suggests that prolific virulence and growth of bacteria, coupled with reduced production of antibodies could limit future space travel A new report appearing in The Journal of Leukocyte Biology (http://www.jleukbio.org) argues that human missions to Mars, as well as all other long-term space flights might be compromised by microbial hitchhikers, such as bacteria. That's because long-term space travel packs a one-two punch to astronauts: first it appears to weaken their immune systems; and second, it increases the virulence and growth of microbes. This combination of factors makes it vital for scientists to find tools that can help people cope with these microscopic hitchhikers before they lead to disease, especially since astronauts will not have the ability to return home to a hospital. "When people think of space travel, often the vast distances are what come to mind first," said Jean-Pol Frippiat, one of the report's co-authors from Nancy-University in France, "but even after we figure out a way to cover these distances in a reasonable amount of time, we still need to figure out how astronauts are going to overcome disease and sickness." Frippiat and colleagues based their conclusions on studies showing that immune systems of both people and animals in space flight conditions are significantly weaker than their grounded counterparts. They also reviewed studies that examined the effects of space flight conditions and altered gravity on virulence and growth of common pathogens such as Salmonella, E. coli and Staphylococcus. These studies show that these bacteria reproduce more rapidly in space flight conditions, leading to increased risk of contamination, colonization and serious infection. "As clearly outlined by the researchers, we are unlikely to remain healthy when leaving earth for prolonged periods," said Luis Montaner, Editor-in-Chief of The Journal of Leukocyte Biology. "Unfortunately, because spacecraft technology is way ahead of our understanding of how to maintain human health, disease-free survival after reaching Mars or establishing a colony on the Moon may be problematic." Federation of American Societies for Experimental Biology |
|||||||||||||||||||||
| Related Leukocyte Biology Current Events and Leukocyte Biology News Articles Oxidized form of a common vitamin may bring relief for ulcerative colitis New research published in the Journal of Leukocyte Biology finds retinoic acid may alleviate ulcerative colitis and similar irritable bowel diseases. Are intravenous treatments safe? New research raises doubts German scientists have identified a serious and previously misunderstood contaminant that brings the safety and efficacy of intravenous treatments into question. Got zinc? New zinc research suggests novel therapeutic targets Everyone knows that vitamins "from A to zinc" are important for good health. Now, a new research study in the August 2009 print issue of the Journal of Leukocyte Biology suggests that zinc may be pointing the way to new therapeutic targets for fighting infections. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. Examining TLR4 influences of B cell response Chronic inflammation, which is at the root of multiple diseases, links periodontal disease to increased incidence of cardiovascular disease. Scientists learn why the flu may turn deadly As the swine flu continues its global spread, researchers from the Children's Hospital of Philadelphia, Pennsylvania, have discovered important clues about why influenza is more severe in some people than it is in others. Just in time for spring: Scientists find the cellular on and off switch for allergies and asthma If you're one of the millions who dread the spring allergy season, things are looking up. New discovery gives tuberculosis vaccine a shot in the arm A new article appearing in the March 2009 issue of the Journal of Leukocyte Biology may lead to improvements in the efficacy of the current tuberculosis vaccine. LIAI launches new division to look at novel approaches to heart disease and inflammation While cholesterol-lowering drugs and new technologies have significantly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease. Case Western Reserve and Penn State investigators inhibit corneal inflammation Researchers from the Case Western Reserve University School of Medicine and Penn State Hershey College of Medicine identified a novel therapeutic that reduces sterile inflammation within the cornea. More Leukocyte Biology Current Events and Leukocyte Biology News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||